Chris Boshoff, Pfizer's new CSO and president of R&D
Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor
Chris Boshoff, the head of Pfizer’s cancer R&D unit, will become the pharma giant’s new chief scientific officer and president of R&D on Jan. 1 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
